Population
cGKI-deficient (cGKI-/-) or endothelial NO synthase-deficient (eNOS-/-) mice, and wild-type mice
Comparison
Intracarotid bolus application of NO donor… vs Wild-type mice
Design
Preclinical
Authors
Loading...
These murine findings should not alter vasodilator use in patients; they leave open cGKI necessity for NO signaling in human resistance vessels.
cGMP and cGKI are major effectors for NO-induced acute dilations in murine resistance vessels, but are not essential for ACh-induced dilation or basal blood pressure regulation.
Koeppen et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: